| Pharmaceutical Biotechnology: Fundamentals and Applications, Third Edition Contributor(s): Crommelin, Daan J. a. (Editor), Sindelar, Robert D. (Editor), Meibohm, Bernd (Editor) |
|
 |
ISBN: 1420044370 ISBN-13: 9781420044379 Publisher: CRC Press OUR PRICE: $99.75 Product Type: Paperback - Other Formats Published: October 2007 Annotation: Completely revised to reflect significant trends and cutting-edge advances in pharmaceutical biotechnology, including specific therapeutic agents and their applications, this Third Edition provides a well-balanced framework for understanding every major aspect of pharmaceutical biotechnology, including drug development, production, dosage forms, administration, and therapeutic developments. New chapters cover oligonucleotides and siRNA, regulatory issues and drug product approval for biopharmaceuticals, immunogenicity, gene therapy, and various monoclonal antibodies grouped by therapeutic area. Self-assessment questions have also been added to each chapter to reinforce understanding of practical pharmaceutical applications, making this an indispensable volume for classroom use as well as for professional reference in practice or industry. |
| Additional Information |
| BISAC Categories: - Medical | Pharmacology - Medical | Biotechnology - Medical | Pharmacy |
| Dewey: 615.19 |
| LCCN: 2007025743 |
| Physical Information: 0.79" H x 8.55" W x 10.95" (3.13 lbs) 512 pages |
| Descriptions, Reviews, Etc. |
| Publisher Description: Completely revised text that reflects to emergent trends and cutting-edge advances in pharmaceutical biotechnology, this Third Edition provides a well-balanced framework for understanding every major aspect of pharmaceutical biotechnology, including drug development, production, dosage forms, administration, and therapeutic developments. New chapters cover evolving areas regarding biopharmaceuticals, including oligonucleotides, siRNA and various monoclonal antibodies, immunogenicity, gene therapy, and the regulatory issues factoring into the biopharmaceutical approval process |